- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Synonyms: KB004
Ifabotuzumab (Anti-EphA3) is a monoclonal antibody against EphA3. MW: 145.28 KD.
| Name | Citation | Ephrin receptor | Others |
|---|---|---|---|
| NVP-BHG712 | 17 | C-Raf,c-Src,c-Abl | |
| ALW II-41-27 | 4 | ||
| Sitravatinib (MGCD516) | 7 | DDR2,Axl,VEGFR3 (FLT4) | |
| NVP-BHG712 isomer | 0 | ||
| AWL-II-38.3 | 0 | ||
| Ehp-inhibitor-1 | 1 |
| Description |
Ifabotuzumab (Anti-EphA3) is a monoclonal antibody against EphA3. MW: 145.28 KD.
|
References |
|---|
| CAS No. | 1234137-51-9 |
|---|---|
| Molecular Weight | 145.28 |
| Isotype | Human IgG1 |
| Source | CHO |
| Purification | AKTA |
| Sterility | 0.2 μM filtered |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.